{"gene":"DCAF5","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":2018,"finding":"DCAF5 is a substrate receptor of the CRL4 ubiquitin E3 ligase complex (CRL4DCAF5). L3MBTL3, a methyl-lysine reader via its MBT domain, binds methylated K142 of DNMT1 and recruits CRL4DCAF5 to ubiquitinate and degrade DNMT1. LSD1 demethylates K142 to prevent this degradation, while PHF20L1 also protects DNMT1 from L3MBTL3-CRL4DCAF5-mediated proteolysis during S phase.","method":"Co-immunoprecipitation, knockdown/knockout rescue experiments, in vivo mouse deletion (L3MBTL3/MBT-1 null), ubiquitination assays, protein stability assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, genetic rescue with KD of DCAF5 restoring DNMT1 levels, mouse KO phenotype, multiple orthogonal methods in one study","pmids":["29691401"],"is_preprint":false},{"year":2018,"finding":"CRL4DCAF5, recruited by L3MBTL3 binding to methylated K142 of DNMT1, also targets E2F1 for methylation-dependent ubiquitin-mediated proteolysis via the same L3MBTL3-CRL4DCAF5 pathway, as E2F1 shares a consensus methylation degron motif with DNMT1.","method":"Protein stability and ubiquitination assays, Co-IP, consensus motif analysis with functional validation","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — same study as DNMT1 finding, supported by multiple methods but E2F1 data is secondary to the main DNMT1 investigation","pmids":["29691401"],"is_preprint":false},{"year":2018,"finding":"L3MBTL3 binds preferentially to methylated K42 of SOX2 (with K117 methylation also contributing) and recruits CRL4DCAF5 to target methylated SOX2 for ubiquitin-dependent proteolysis. Knockdown of DCAF5 restores SOX2 protein levels and rescues self-renewal and pluripotency defects in mouse ES cells caused by LSD1 or PHF20L1 deficiency.","method":"Co-immunoprecipitation, siRNA knockdown, protein stability assays, mouse ES cell self-renewal and pluripotency rescue assays, site-directed mutagenesis of SOX2 K42 and K117","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, mutagenesis of methylation sites, genetic rescue of cellular phenotype, multiple orthogonal methods","pmids":["30442713"],"is_preprint":false},{"year":2024,"finding":"DCAF5 functions as a quality-control E3 ligase receptor for SWI/SNF complexes, promoting degradation of incompletely assembled SWI/SNF complexes that lack SMARCB1. Loss of DCAF5 in SMARCB1-mutant cancer cells causes reaccumulation of SMARCB1-deficient SWI/SNF complexes, restored binding to target loci, restored SWI/SNF-mediated gene expression, and reversal of the cancer state both in vitro and in vivo.","method":"Genome-wide CRISPR screen, DCAF5 depletion (siRNA/CRISPRi), Co-immunoprecipitation of SWI/SNF complexes, chromatin immunoprecipitation (ChIP), gene expression analysis, in vivo mouse xenograft models","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide CRISPR screen, multiple cell lines (14 SMARCB1-mutant), Co-IP of complexes, ChIP, in vivo validation, multiple orthogonal methods","pmids":["38538798"],"is_preprint":false},{"year":2024,"finding":"EZH2, the catalytic subunit of PRC2, is methylated at K20 by an unspecified methyltransferase, and this methylation targets EZH2 for proteolysis by L3MBTL3 and the CRL4DCAF5 ubiquitin ligase. KDM1A (LSD1) demethylates K20 to stabilize EZH2. AKT-mediated phosphorylation of S21 in EZH2 inhibits K20 methylation, establishing a methylation-phosphorylation switch. Mouse null mutation of Dcaf5 results in PRC2 accumulation and increased H3K27 trimethylation.","method":"Mouse Dcaf5 null mutation, protein stability assays, Co-immunoprecipitation, in vivo methylation and phosphorylation assays, Ezh2 K20R knock-in mouse mutant analysis, hematopoietic stem cell phenotyping","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse KO and knock-in models, multiple biochemical assays, genetic epistasis with Kdm1a deletion, orthogonal methods","pmids":["38346162"],"is_preprint":false},{"year":2022,"finding":"The L3MBTL3-CRL4DCAF5 methyl-reader:E3 ligase complex can be co-opted by bifunctional PROTAC molecules (L3MBTL3-recruiting PROTACs) to induce nuclear-specific degradation of non-natural substrates (FKBP12 and BRD2), demonstrating that CRL4DCAF5 is functional and accessible for targeted protein degradation in the nucleus.","method":"PROTAC design and synthesis, cell-based protein degradation assays, nuclear localization studies, dose-response degradation experiments","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based degradation assays with synthetic molecules, nuclear specificity demonstrated, single lab","pmids":["35311258"],"is_preprint":false}],"current_model":"DCAF5 is the substrate receptor of the CRL4DCAF5 E3 ubiquitin ligase complex, which, upon recruitment by the methyl-lysine reader protein L3MBTL3, ubiquitinates and degrades multiple methylated non-histone proteins (DNMT1, E2F1, SOX2, EZH2) via a conserved lysine methylation degron pathway; additionally, DCAF5 performs quality-control surveillance of SWI/SNF chromatin-remodeling complexes by promoting degradation of incompletely assembled (SMARCB1-deficient) complexes, a function exploited by SMARCB1-mutant cancers."},"narrative":{"mechanistic_narrative":"DCAF5 is the substrate-receptor subunit of a CRL4 (Cullin-4 RING) E3 ubiquitin ligase that enforces protein turnover through a conserved lysine-methylation degron pathway and through quality-control surveillance of chromatin-remodeling complexes [PMID:29691401, PMID:38538798]. In the methylation-degron arm, the methyl-lysine reader L3MBTL3 binds methylated lysines on non-histone substrates and recruits CRL4DCAF5 to ubiquitinate and degrade them; this circuit controls DNMT1 (methyl-K142), with the demethylase LSD1 and the reader PHF20L1 opposing degradation to stabilize the substrate [PMID:29691401]. The same L3MBTL3-CRL4DCAF5 module, recognizing a shared methylation degron motif, targets E2F1, the pluripotency factor SOX2 (methyl-K42/K117), and the PRC2 catalytic subunit EZH2 (methyl-K20), where LSD1-mediated demethylation and AKT-dependent phosphorylation set an opposing methylation-phosphorylation switch; loss of Dcaf5 in mice causes PRC2 accumulation and increased H3K27 trimethylation [PMID:29691401, PMID:30442713, PMID:38346162]. Through SOX2 control, DCAF5 depletion restores self-renewal and pluripotency in LSD1- or PHF20L1-deficient ES cells [PMID:30442713]. Independently of the methyl-reader pathway, DCAF5 acts as a quality-control receptor that degrades incompletely assembled, SMARCB1-deficient SWI/SNF complexes; its loss in SMARCB1-mutant cancer cells permits reaccumulation of residual SWI/SNF complexes, restoration of target-locus binding and gene expression, and reversal of the malignant state in vivo [PMID:38538798]. The complex is accessible for nuclear targeted degradation, as L3MBTL3-recruiting PROTACs redirect CRL4DCAF5 onto non-natural substrates [PMID:35311258].","teleology":[{"year":2018,"claim":"Establishing how methylated non-histone proteins are cleared, this work identified DCAF5 as the CRL4 substrate receptor that, via the methyl-lysine reader L3MBTL3, recognizes and degrades methyl-K142 DNMT1, defining a methylation-degron proteolysis axis.","evidence":"Co-IP, knockdown/knockout rescue restoring DNMT1, in vivo L3MBTL3-null mice, and ubiquitination/stability assays","pmids":["29691401"],"confidence":"High","gaps":["Structure of the L3MBTL3-CRL4DCAF5-substrate complex not resolved","Methyltransferase generating the DNMT1 K142 mark within this pathway not defined here","DCAF5-CUL4 binding interface not biochemically mapped"]},{"year":2018,"claim":"Generalizing the degron, the same study showed E2F1 carries a consensus methylation degron shared with DNMT1 and is degraded through the L3MBTL3-CRL4DCAF5 pathway, indicating the receptor recognizes a motif rather than a single protein.","evidence":"Protein stability and ubiquitination assays, Co-IP, and consensus motif analysis with functional validation","pmids":["29691401"],"confidence":"Medium","gaps":["E2F1 data secondary to the DNMT1 investigation, lacking dedicated in vivo confirmation","Physiological context regulating E2F1 methylation/degradation not established"]},{"year":2018,"claim":"Linking the pathway to stem-cell identity, methylated SOX2 (K42, K117) was shown to be an L3MBTL3-CRL4DCAF5 substrate, and DCAF5 knockdown restored SOX2 and rescued self-renewal/pluripotency defects of LSD1- or PHF20L1-deficient ES cells.","evidence":"Co-IP, siRNA knockdown, K42/K117 mutagenesis, protein stability assays, and ES cell self-renewal/pluripotency rescue","pmids":["30442713"],"confidence":"High","gaps":["Methyltransferase writing SOX2 K42/K117 not identified","Relative contribution of K42 vs K117 not fully partitioned"]},{"year":2024,"claim":"Extending the degron to a chromatin regulator, methyl-K20 EZH2 was shown to be degraded by L3MBTL3-CRL4DCAF5, with LSD1 demethylation and AKT phosphorylation of S21 forming a methylation-phosphorylation switch; Dcaf5-null mice accumulate PRC2 and H3K27me3.","evidence":"Dcaf5-null and Ezh2 K20R knock-in mice, stability and methylation/phosphorylation assays, Co-IP, and HSC phenotyping","pmids":["38346162"],"confidence":"High","gaps":["Identity of the EZH2 K20 methyltransferase unspecified","Whether PRC2 accumulation is fully attributable to direct EZH2 degradation vs indirect effects not isolated"]},{"year":2024,"claim":"Revealing a methyl-reader-independent role, a genome-wide screen identified DCAF5 as a quality-control E3 receptor that degrades SMARCB1-deficient SWI/SNF complexes, with its loss restoring functional SWI/SNF and reversing the SMARCB1-mutant cancer state.","evidence":"Genome-wide CRISPR screen, DCAF5 depletion across 14 SMARCB1-mutant lines, SWI/SNF Co-IP, ChIP, expression analysis, and mouse xenografts","pmids":["38538798"],"confidence":"High","gaps":["Degron/recognition feature on misassembled SWI/SNF not defined","Whether L3MBTL3 or methylation participates in this surveillance not addressed","Ubiquitination sites on SWI/SNF subunits not mapped"]},{"year":2022,"claim":"Demonstrating pharmacological tractability, L3MBTL3-recruiting PROTACs co-opted CRL4DCAF5 to degrade non-natural nuclear substrates (FKBP12, BRD2), showing the ligase is functional and accessible for targeted degradation in the nucleus.","evidence":"PROTAC synthesis, cell-based degradation and dose-response assays, and nuclear localization studies","pmids":["35311258"],"confidence":"Medium","gaps":["Single-lab synthetic-substrate demonstration without in vivo validation","Ternary complex structure and degradation efficiency relative to native substrates not established"]},{"year":null,"claim":"How DCAF5 distinguishes its methylation-degron substrates from its SWI/SNF quality-control targets, and whether a single recognition mechanism underlies both, remains unresolved.","evidence":"No discovery in the corpus reconciles the L3MBTL3-dependent and SWI/SNF surveillance activities mechanistically","pmids":[],"confidence":"Low","gaps":["No structural model of DCAF5 substrate recognition","Whether the two activities use overlapping or distinct interaction surfaces unknown","Identity of the methyltransferases generating the degron marks not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[3,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3]}],"complexes":["CRL4DCAF5"],"partners":["L3MBTL3","DNMT1","E2F1","SOX2","EZH2","SMARCB1","CUL4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96JK2","full_name":"DDB1- and CUL4-associated factor 5","aliases":["Breakpoint cluster region protein 2","BCRP2","WD repeat-containing protein 22"],"length_aa":942,"mass_kda":104.0,"function":"Is a substrate receptor for the CUL4-DDB1 E3 ubiquitin-protein ligase complex (CRL4) (PubMed:29691401, PubMed:30442713). The complex CRL4-DCAF5 is involved in the ubiquitination of a set of methylated non-histone proteins, including SOX2, DNMT1 and E2F1 (PubMed:29691401, PubMed:30442713)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q96JK2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCAF5","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DDB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DCAF5","total_profiled":1310},"omim":[{"mim_id":"618844","title":"L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 3; L3MBTL3","url":"https://www.omim.org/entry/618844"},{"mim_id":"603812","title":"DDB1- AND CUL4-ASSOCIATED FACTOR 5; DCAF5","url":"https://www.omim.org/entry/603812"},{"mim_id":"184429","title":"SRY-BOX 2; SOX2","url":"https://www.omim.org/entry/184429"},{"mim_id":"179617","title":"RAD51 RECOMBINASE; RAD51","url":"https://www.omim.org/entry/179617"},{"mim_id":"114480","title":"BREAST CANCER","url":"https://www.omim.org/entry/114480"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DCAF5"},"hgnc":{"alias_symbol":["BCRP2","D14S1461E","BCRG2","KIAA1824"],"prev_symbol":["WDR22"]},"alphafold":{"accession":"Q96JK2","domains":[{"cath_id":"2.130.10.10","chopping":"15-382","consensus_level":"high","plddt":91.6933,"start":15,"end":382},{"cath_id":"-","chopping":"388-433","consensus_level":"high","plddt":79.9602,"start":388,"end":433}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JK2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96JK2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96JK2-F1-predicted_aligned_error_v6.png","plddt_mean":60.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCAF5","jax_strain_url":"https://www.jax.org/strain/search?query=DCAF5"},"sequence":{"accession":"Q96JK2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96JK2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96JK2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JK2"}},"corpus_meta":[{"pmid":"29691401","id":"PMC_29691401","title":"Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29691401","citation_count":52,"is_preprint":false},{"pmid":"38538798","id":"PMC_38538798","title":"Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.","date":"2024","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/38538798","citation_count":49,"is_preprint":false},{"pmid":"30442713","id":"PMC_30442713","title":"Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4DCAF5 ubiquitin ligase.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30442713","citation_count":39,"is_preprint":false},{"pmid":"35311258","id":"PMC_35311258","title":"Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation.","date":"2022","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/35311258","citation_count":31,"is_preprint":false},{"pmid":"24357125","id":"PMC_24357125","title":"Deletions in 14q24.1q24.3 are associated with congenital heart defects, brachydactyly, and mild intellectual disability.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24357125","citation_count":20,"is_preprint":false},{"pmid":"38396925","id":"PMC_38396925","title":"Lysine Methylation-Dependent Proteolysis by the Malignant Brain Tumor (MBT) Domain Proteins.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38396925","citation_count":7,"is_preprint":false},{"pmid":"38346162","id":"PMC_38346162","title":"A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38346162","citation_count":7,"is_preprint":false},{"pmid":"37605116","id":"PMC_37605116","title":"Genome-wide scan for runs of homozygosity in South American Camelids.","date":"2023","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37605116","citation_count":6,"is_preprint":false},{"pmid":"9740667","id":"PMC_9740667","title":"Genomic and functional map of the chromosome 14 t(12;14) breakpoint cluster region in uterine leiomyoma.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9740667","citation_count":5,"is_preprint":false},{"pmid":"35627254","id":"PMC_35627254","title":"Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35627254","citation_count":3,"is_preprint":false},{"pmid":"40291381","id":"PMC_40291381","title":"A genome-wide association study identifies novel genetic variants associated with neck or shoulder pain in the UK biobank (N = 430,193).","date":"2025","source":"Pain reports","url":"https://pubmed.ncbi.nlm.nih.gov/40291381","citation_count":1,"is_preprint":false},{"pmid":"41958871","id":"PMC_41958871","title":"Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer's disease neuropathology.","date":"2026","source":"NPJ dementia","url":"https://pubmed.ncbi.nlm.nih.gov/41958871","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.28.666515","title":"Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer’s disease neuropathology","date":"2025-07-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.28.666515","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8958,"output_tokens":1935,"usd":0.027949,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8775,"output_tokens":3130,"usd":0.061062,"stage2_stop_reason":"end_turn"},"total_usd":0.089011,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"DCAF5 is a substrate receptor of the CRL4 ubiquitin E3 ligase complex (CRL4DCAF5). L3MBTL3, a methyl-lysine reader via its MBT domain, binds methylated K142 of DNMT1 and recruits CRL4DCAF5 to ubiquitinate and degrade DNMT1. LSD1 demethylates K142 to prevent this degradation, while PHF20L1 also protects DNMT1 from L3MBTL3-CRL4DCAF5-mediated proteolysis during S phase.\",\n      \"method\": \"Co-immunoprecipitation, knockdown/knockout rescue experiments, in vivo mouse deletion (L3MBTL3/MBT-1 null), ubiquitination assays, protein stability assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, genetic rescue with KD of DCAF5 restoring DNMT1 levels, mouse KO phenotype, multiple orthogonal methods in one study\",\n      \"pmids\": [\"29691401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRL4DCAF5, recruited by L3MBTL3 binding to methylated K142 of DNMT1, also targets E2F1 for methylation-dependent ubiquitin-mediated proteolysis via the same L3MBTL3-CRL4DCAF5 pathway, as E2F1 shares a consensus methylation degron motif with DNMT1.\",\n      \"method\": \"Protein stability and ubiquitination assays, Co-IP, consensus motif analysis with functional validation\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — same study as DNMT1 finding, supported by multiple methods but E2F1 data is secondary to the main DNMT1 investigation\",\n      \"pmids\": [\"29691401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"L3MBTL3 binds preferentially to methylated K42 of SOX2 (with K117 methylation also contributing) and recruits CRL4DCAF5 to target methylated SOX2 for ubiquitin-dependent proteolysis. Knockdown of DCAF5 restores SOX2 protein levels and rescues self-renewal and pluripotency defects in mouse ES cells caused by LSD1 or PHF20L1 deficiency.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, protein stability assays, mouse ES cell self-renewal and pluripotency rescue assays, site-directed mutagenesis of SOX2 K42 and K117\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, mutagenesis of methylation sites, genetic rescue of cellular phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"30442713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DCAF5 functions as a quality-control E3 ligase receptor for SWI/SNF complexes, promoting degradation of incompletely assembled SWI/SNF complexes that lack SMARCB1. Loss of DCAF5 in SMARCB1-mutant cancer cells causes reaccumulation of SMARCB1-deficient SWI/SNF complexes, restored binding to target loci, restored SWI/SNF-mediated gene expression, and reversal of the cancer state both in vitro and in vivo.\",\n      \"method\": \"Genome-wide CRISPR screen, DCAF5 depletion (siRNA/CRISPRi), Co-immunoprecipitation of SWI/SNF complexes, chromatin immunoprecipitation (ChIP), gene expression analysis, in vivo mouse xenograft models\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide CRISPR screen, multiple cell lines (14 SMARCB1-mutant), Co-IP of complexes, ChIP, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"38538798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EZH2, the catalytic subunit of PRC2, is methylated at K20 by an unspecified methyltransferase, and this methylation targets EZH2 for proteolysis by L3MBTL3 and the CRL4DCAF5 ubiquitin ligase. KDM1A (LSD1) demethylates K20 to stabilize EZH2. AKT-mediated phosphorylation of S21 in EZH2 inhibits K20 methylation, establishing a methylation-phosphorylation switch. Mouse null mutation of Dcaf5 results in PRC2 accumulation and increased H3K27 trimethylation.\",\n      \"method\": \"Mouse Dcaf5 null mutation, protein stability assays, Co-immunoprecipitation, in vivo methylation and phosphorylation assays, Ezh2 K20R knock-in mouse mutant analysis, hematopoietic stem cell phenotyping\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse KO and knock-in models, multiple biochemical assays, genetic epistasis with Kdm1a deletion, orthogonal methods\",\n      \"pmids\": [\"38346162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The L3MBTL3-CRL4DCAF5 methyl-reader:E3 ligase complex can be co-opted by bifunctional PROTAC molecules (L3MBTL3-recruiting PROTACs) to induce nuclear-specific degradation of non-natural substrates (FKBP12 and BRD2), demonstrating that CRL4DCAF5 is functional and accessible for targeted protein degradation in the nucleus.\",\n      \"method\": \"PROTAC design and synthesis, cell-based protein degradation assays, nuclear localization studies, dose-response degradation experiments\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based degradation assays with synthetic molecules, nuclear specificity demonstrated, single lab\",\n      \"pmids\": [\"35311258\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCAF5 is the substrate receptor of the CRL4DCAF5 E3 ubiquitin ligase complex, which, upon recruitment by the methyl-lysine reader protein L3MBTL3, ubiquitinates and degrades multiple methylated non-histone proteins (DNMT1, E2F1, SOX2, EZH2) via a conserved lysine methylation degron pathway; additionally, DCAF5 performs quality-control surveillance of SWI/SNF chromatin-remodeling complexes by promoting degradation of incompletely assembled (SMARCB1-deficient) complexes, a function exploited by SMARCB1-mutant cancers.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DCAF5 is the substrate-receptor subunit of a CRL4 (Cullin-4 RING) E3 ubiquitin ligase that enforces protein turnover through a conserved lysine-methylation degron pathway and through quality-control surveillance of chromatin-remodeling complexes [#0, #3]. In the methylation-degron arm, the methyl-lysine reader L3MBTL3 binds methylated lysines on non-histone substrates and recruits CRL4DCAF5 to ubiquitinate and degrade them; this circuit controls DNMT1 (methyl-K142), with the demethylase LSD1 and the reader PHF20L1 opposing degradation to stabilize the substrate [#0]. The same L3MBTL3-CRL4DCAF5 module, recognizing a shared methylation degron motif, targets E2F1, the pluripotency factor SOX2 (methyl-K42/K117), and the PRC2 catalytic subunit EZH2 (methyl-K20), where LSD1-mediated demethylation and AKT-dependent phosphorylation set an opposing methylation-phosphorylation switch; loss of Dcaf5 in mice causes PRC2 accumulation and increased H3K27 trimethylation [#1, #2, #4]. Through SOX2 control, DCAF5 depletion restores self-renewal and pluripotency in LSD1- or PHF20L1-deficient ES cells [#2]. Independently of the methyl-reader pathway, DCAF5 acts as a quality-control receptor that degrades incompletely assembled, SMARCB1-deficient SWI/SNF complexes; its loss in SMARCB1-mutant cancer cells permits reaccumulation of residual SWI/SNF complexes, restoration of target-locus binding and gene expression, and reversal of the malignant state in vivo [#3]. The complex is accessible for nuclear targeted degradation, as L3MBTL3-recruiting PROTACs redirect CRL4DCAF5 onto non-natural substrates [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2018,\n      \"claim\": \"Establishing how methylated non-histone proteins are cleared, this work identified DCAF5 as the CRL4 substrate receptor that, via the methyl-lysine reader L3MBTL3, recognizes and degrades methyl-K142 DNMT1, defining a methylation-degron proteolysis axis.\",\n      \"evidence\": \"Co-IP, knockdown/knockout rescue restoring DNMT1, in vivo L3MBTL3-null mice, and ubiquitination/stability assays\",\n      \"pmids\": [\"29691401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure of the L3MBTL3-CRL4DCAF5-substrate complex not resolved\",\n        \"Methyltransferase generating the DNMT1 K142 mark within this pathway not defined here\",\n        \"DCAF5-CUL4 binding interface not biochemically mapped\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Generalizing the degron, the same study showed E2F1 carries a consensus methylation degron shared with DNMT1 and is degraded through the L3MBTL3-CRL4DCAF5 pathway, indicating the receptor recognizes a motif rather than a single protein.\",\n      \"evidence\": \"Protein stability and ubiquitination assays, Co-IP, and consensus motif analysis with functional validation\",\n      \"pmids\": [\"29691401\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"E2F1 data secondary to the DNMT1 investigation, lacking dedicated in vivo confirmation\",\n        \"Physiological context regulating E2F1 methylation/degradation not established\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking the pathway to stem-cell identity, methylated SOX2 (K42, K117) was shown to be an L3MBTL3-CRL4DCAF5 substrate, and DCAF5 knockdown restored SOX2 and rescued self-renewal/pluripotency defects of LSD1- or PHF20L1-deficient ES cells.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, K42/K117 mutagenesis, protein stability assays, and ES cell self-renewal/pluripotency rescue\",\n      \"pmids\": [\"30442713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Methyltransferase writing SOX2 K42/K117 not identified\",\n        \"Relative contribution of K42 vs K117 not fully partitioned\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extending the degron to a chromatin regulator, methyl-K20 EZH2 was shown to be degraded by L3MBTL3-CRL4DCAF5, with LSD1 demethylation and AKT phosphorylation of S21 forming a methylation-phosphorylation switch; Dcaf5-null mice accumulate PRC2 and H3K27me3.\",\n      \"evidence\": \"Dcaf5-null and Ezh2 K20R knock-in mice, stability and methylation/phosphorylation assays, Co-IP, and HSC phenotyping\",\n      \"pmids\": [\"38346162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the EZH2 K20 methyltransferase unspecified\",\n        \"Whether PRC2 accumulation is fully attributable to direct EZH2 degradation vs indirect effects not isolated\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealing a methyl-reader-independent role, a genome-wide screen identified DCAF5 as a quality-control E3 receptor that degrades SMARCB1-deficient SWI/SNF complexes, with its loss restoring functional SWI/SNF and reversing the SMARCB1-mutant cancer state.\",\n      \"evidence\": \"Genome-wide CRISPR screen, DCAF5 depletion across 14 SMARCB1-mutant lines, SWI/SNF Co-IP, ChIP, expression analysis, and mouse xenografts\",\n      \"pmids\": [\"38538798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Degron/recognition feature on misassembled SWI/SNF not defined\",\n        \"Whether L3MBTL3 or methylation participates in this surveillance not addressed\",\n        \"Ubiquitination sites on SWI/SNF subunits not mapped\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating pharmacological tractability, L3MBTL3-recruiting PROTACs co-opted CRL4DCAF5 to degrade non-natural nuclear substrates (FKBP12, BRD2), showing the ligase is functional and accessible for targeted degradation in the nucleus.\",\n      \"evidence\": \"PROTAC synthesis, cell-based degradation and dose-response assays, and nuclear localization studies\",\n      \"pmids\": [\"35311258\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab synthetic-substrate demonstration without in vivo validation\",\n        \"Ternary complex structure and degradation efficiency relative to native substrates not established\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DCAF5 distinguishes its methylation-degron substrates from its SWI/SNF quality-control targets, and whether a single recognition mechanism underlies both, remains unresolved.\",\n      \"evidence\": \"No discovery in the corpus reconciles the L3MBTL3-dependent and SWI/SNF surveillance activities mechanistically\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of DCAF5 substrate recognition\",\n        \"Whether the two activities use overlapping or distinct interaction surfaces unknown\",\n        \"Identity of the methyltransferases generating the degron marks not established\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\"CRL4DCAF5\"],\n    \"partners\": [\"L3MBTL3\", \"DNMT1\", \"E2F1\", \"SOX2\", \"EZH2\", \"SMARCB1\", \"CUL4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}